Zyngenia, Inc., a biopharmaceutical company, engages in the development of multi-specific antibody-based drugs in the United States. It focuses on the development of therapies for various cancers and autoimmune disorders. The company was incorporated in 2008 and is based in Gaithersburg, Maryland.